The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Trump Affordability Czar Defends Medicaid Cuts to Hospitals

Casey Mulligan, the economist serving as the Trump administration's health care affordability czar, used a speech to hospital finance leaders to argue that looming Medicaid cuts will make care more affordable, according to STAT News. The message landed in a room full of executives who stand to absorb much of the financial damage.

Mulligan delivered the remarks at a Healthcare Financial Management Association gathering, framing the reductions as part of the administration's broader affordability agenda. Hospital leaders in attendance offered a different read, telling STAT News they are already working to mitigate the impacts of the cuts on their operations and patients.

The tension is straightforward. Medicaid is a major payer for hospitals, especially those serving low-income and rural communities, and reduced funding squeezes margins that are already thin. Providers now face decisions about service lines, staffing, and how to cover care for patients who could lose coverage. The gap between Washington's affordability framing and hospital finance reality is the story to watch as the cuts take shape.

Sources

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.